Latest Conference Coverage
Gaining a Better Understanding of Idiopathic Hypersomnia, Uses of Low-Sodium Oxybate
June 27th 2023Marisa Whalen, PharmD, associate director of Medical Affairs at Jazz Pharmaceuticals, discussed presentations at SLEEP 2023 on the real-world burdens of idiopathic hypersomnia and the smooth transition to low sodium oxybate in patients with narcolepsy.
Patient Perspectives and the Importance of Advocacy and Support in Parkinson Disease: Lori DePorter
June 26th 2023At ATMRD 2023, Lori DePorter, global ambassador for the PMD alliance, talked from the patient experience about the need for improved communication between care teams and support groups in Parkinson disease. [WATCH TIME: 3 minutes]
Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MS
June 26th 2023The sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University discussed the multi-level effort needed to improve sleep issues seen in individuals most impacted by social determinants of health. [WATCH TIME: 3 minutes]
Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS
June 25th 2023The assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]
Gut-Brain Interaction, the Overlapping Connection Between Cyclic Vomiting and Migraine
June 23rd 2023B U. K. Li, MD, emeritus professor of pediatrics and gastroenterology at the Medical College of Wisconsin, highlights the significant overlap between cyclic vomiting syndrome, abdominal migraine, and migraine headaches.
Benefits and Risks of Opioid Use in Restless Legs Syndrome: John Winkelman, MD, PhD
June 22nd 2023The chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital discussed the benefits opioids have for patients with restless legs syndrome, as well as how they can be safely used as part of treatment strategies. [WATCH TIME: 4 minutes]
Insights on Sunobinop As a Treatment for Insomnia in Patients Recovering From Alcohol Use Disorder
June 22nd 2023Garth T. Whiteside, PhD, head of preclinical development at Imbrium Therapeutics, discussed a phase 2 clinical study that explored the use of sunobinop in patients with insomnia during recovery from alcohol use disorder.
Galcanezumab Shows Greatest Reduction in Disease Burden Following Switching
June 21st 2023Following the initiation or switch to a new migraine preventive medication, patients taking galcanezumab showed numerically greater 3-month improvements for most measures of health-related quality of life and disability.
Management and Impact of Migraine During Pregnancy: Rashmi Halker Singh, MD
June 21st 2023The associate professor of neurology at Mayo Clinic discussed the developing field of migraine management during pregnancy and the importance of raising awareness of treatment options during the gestation period. [WATCH TIME: 4 minutes]
NeuroVoices: Sara Pavitt, MD, on the Need to Educate the Clinical Community on Pediatric Headache
June 21st 2023At the 2023 AHS Annual Meeting, the chief of headache at UT Austin Dell Children’s Hospital discussed her presentation on a new educational intervention to improve knowledge of pediatric headache.
Entering a New Realm of Migraine Treatment, Research Priorities
June 20th 2023Walter Koroshetz, MD, director of the National Institutes of Neurological Disorders and Stroke at the NIH, provided perspective on the advances in migraine treatment, and the next steps in research needed over the coming years.
Approach to Cannabis and Optimizing Treatment for Migraine: Nathaniel Schuster, MD
June 19th 2023The pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine provided perspective on how cannabis may be used in the management of migraine as more evidence is uncovered. [WATCH TIME: 3 minutes]
Zavegepant Tolerable, Safe When Used in Combination With Other CGRP Monoclonal Antibodies
June 19th 2023Data showed similar rates of discontinuation because of adverse events between those with and without CGRP monoclonal antibodies, as well as no serious AEs observed for those on concomitant medication.
Intravenous Ketamine Significantly Reduces Pain in Refractory Pediatric Headache
June 19th 2023The use of intravenous ketamine in pediatric patients with refractory headaches resulted in a median pain reduction of 50% at discharge and nearly two-third of patients did not need further rescue therapies 1 month posttreatment.
Exploring Behavioral Approaches in Migraine Management: Elizabeth Seng, PhD
June 19th 2023The associate professor at Yeshiva University and Albert Einstein College of Medicine discussed the significance of recognizing the behavioral aspects of migraine management such as lifestyle choices, medical interventions, and societal influences. [WATCH TIME: 4 minutes]
How Retinal Imaging Reveals Alterations During Migraine Attacks: Katherine Podraza, MD, PhD
June 18th 2023The headache specialist at the Hartford Healthcare Headache Center discussed a study that explored changes in the vasculature and retinal blood perfusion of the eye during migraine attacks. [WATCH TIME: 5 minutes]
Using a Data-Driven Approach to Assess Clinical Heterogeneity in Migraine: Ali Ezzati, MD
June 18th 2023The director of the Neuroinformatics Program at the University of California, Irvine, provided insight on the use of self-organizing maps to cluster different groups of patients with migraine. [WATCH TIME: 4 minutes]
Use of Vaporized Cannabis as a Potential Treatment for Migraine: Nathaniel Schuster, MD
June 17th 2023The pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine discussed promising findings from a placebo-controlled trial assessing cannabis in patients with migraine. [WATCH TIME: 5 minutes]
Behavioral Strategies for Management and Destigmatizing Migraine
June 17th 2023Elizabeth K. Seng, PhD, associate professor at Yeshiva University and Albert Einstein College of Medicine, talked about migraine management through the lens of behavioral factors that clinicians can recommend and encourage to their patients.
Defining Research Priorities in Migraine Through Crowdsourcing: Amynah Pradhan, PhD
June 17th 2023The associate professor of psychiatry at the University of Illinois at Chicago discussed the various working groups that have been formed to determine the priorities for different topics in migraine at the 2023 AHS Annual Meeting. [WATCH TIME: 5 minutes]
Migraine Related Stigma and its Impact on Patients in Healthcare
June 17th 2023Allison Verhaak, PhD, a clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center, discussed focus group and survey data on themes in migraine-related stigma, and the importance of creating a migraine specific stigma scale.
